Clinical Trial Update: Intravitreal Aflibercept for Macular Edema Due to Central Retinal Vein Occlusion [Phase 4]

View source ↗

Summary

Phase 4 study evaluating intravitreal aflibercept for macular edema due to central retinal vein occlusion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: University of Athens | Conditions: Retinal Vein Occlusion, Vascular Occlusive Disease | Phase 4 | Status: COMPLETED